Ghent University Academic Bibliography

Your filters: cql: author="Horakova, Dana" or (type any "bookEditor issueEditor" and editor="Horakova, Dana")

Add to list
Moderate–high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosis

Yi Chao Foong, Daniel Merlo, Melissa Gresle, Katherine Buzzard, Dana Horakova, Eva Kubala Havrdova, Tomas Kalincik, Izanne Roos, Suzanne Hodgkinson, Jeannette Lechner-Scott, et al.

(2026) JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 97(1). p.50-58
Add to list
- Journal Article
- A1
- open access
Progression independent of relapse activity and relapse-associated worsening in seronegative NMOSD : an international cohort study

Pakeeran Siriratnam, Saif Huda, Anneke Van der Walt, Paul Sanfilippo, Sifat Sharmin, Yi Chao Foong, Wei Zhen Yeh, Chao Zhu, Samia J. Khoury, Tunde Csepany, et al.

(2025) JOURNAL OF NEUROLOGY. 272(5).
Add to list
- Journal Article
- A2
- open access
Relationship between brain atrophy and disability in a multi-site multiple sclerosis registry

Ai-Lan Nguyen, Dana Horakova, Eva H Havrdova, Michael Barnett, Maria Pia Sormani, Nicola De Stefano, Marco Battaglini, Manuela Vaneckova, Elaine Lui, Frank Gaillard, et al.

(2025) BMJ NEUROLOGY OPEN. 7(2).
Add to list
Corticosteroid treatment of multiple sclerosis relapses is associated with lower disability worsening over 5 years

Jodie I Roberts, Sifat Sharmin, Dana Horakova, Eva Kubala Havrdova, Serkan Ozakbas, Alessandra Lugaresi, Valentina Tomassini, Raed Alroughani, Katherine Buzzard, Olga Skibina, et al.

(2025) JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 96(12). p.1185-1193
Add to list
- Journal Article
- A2
- open access
Persistent progression independent of relapse activity in multiple sclerosis

Chao Zhu, Zhen Zhou, Tomas Kalincik, Izanne Roos, Katherine Buzzard, Olga Skibina, Raed Alroughani, Jens Kuhle, Marc Girard, Pierre Grammond, et al.

(2025) BRAIN COMMUNICATIONS. 7(5).
Add to list
- Journal Article
- A1
- open access
Personalized federated learning for predicting disability progression in multiple sclerosis using real-world routine clinical data

Ashkan Pirmani, Edward De Brouwer, Ádám Arany, Martijn Oldenhof, Antoine Passemiers, Axel Faes, Tomas Kalincik, Serkan Ozakbas, Riadh Gouider, Barbara Willekens, et al.

(2025) NPJ DIGITAL MEDICINE. 8(1).
Add to list
Standardized definition of Progression Independent of Relapse Activity (PIRA) in relapsing-remitting multiple sclerosis

Jannis Müller, Sifat Sharmin, Johannes Lorscheider, Serkan Ozakbas, Rana Karabudak, Dana Horakova, Bianca Weinstock-Guttman, Vahid Shaygannejad, Masoud Etemadifar, Raed Alroughani, et al.

(2025) JAMA NEUROLOGY. 82(6). p.614-625
Add to list
- Journal Article
- A1
- open access
Four years on : pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women’s Health Registry (2020–2024)

Vilija G Jokubaitis, Raed Alroughani, Ayse Altintas, Sara Eichau, Stella Hughes, Barbara Willekens, Dana Horakova, Eva Kubala Havrdova, Serkan Ozakbas, Cavit Boz, et al.

(2025) MULTIPLE SCLEROSIS JOURNAL. 31(9). p.1088-1101
Add to list
- Journal Article
- A1
- open access
Pregnancy-related disease outcomes in women with moderate to severe multiple sclerosis disability

Jessica Shipley, Heidi N. Beadnall, Paul G. Sanfilippo, Wei Zhen Yeh, Dana Horakova, Eva Kubala Havrdova, Pavel Hradilek, Tomas Kalincik, Izanne Roos, Alexandre Prat, et al.

(2025) JAMA NETWORK OPEN. 8(9).
Add to list
- Journal Article
- A1
- open access
Managing reactivation of multiple sclerosis during treatment with natalizumab

Nathaniel Lizak, Sifat Sharmin, Dana Horáková, Eva Kubala Havrdova, Sara Eichau, Anneke van der Walt, Helmut Butzkueven, Jeannette Lechner-Scott, Katherine Buzzard, Olga Skibina, et al.

(2025) MULTIPLE SCLEROSIS JOURNAL. 32(1). p.121-133

Academic Bibliography

Moderate–high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosis

Progression independent of relapse activity and relapse-associated worsening in seronegative NMOSD : an international cohort study

Relationship between brain atrophy and disability in a multi-site multiple sclerosis registry

Corticosteroid treatment of multiple sclerosis relapses is associated with lower disability worsening over 5 years

Persistent progression independent of relapse activity in multiple sclerosis

Personalized federated learning for predicting disability progression in multiple sclerosis using real-world routine clinical data

Standardized definition of Progression Independent of Relapse Activity (PIRA) in relapsing-remitting multiple sclerosis

Four years on : pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women’s Health Registry (2020–2024)

Pregnancy-related disease outcomes in women with moderate to severe multiple sclerosis disability

Managing reactivation of multiple sclerosis during treatment with natalizumab

Contents

Support

Contact